Pieter Sonneveld Selected Research

Painful Neuropathy

1/2018	Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain.
1/2015	Chemotherapy-induced peripheral neuropathies in hematological malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pieter Sonneveld Research Topics

Disease

195	Multiple Myeloma 04/2024 - 03/2003
25	Neoplasms (Cancer) 04/2024 - 01/2005
19	Disease Progression 01/2024 - 06/2005
13	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 01/2006
11	Neutropenia 10/2023 - 10/2008
11	Thrombocytopenia (Thrombopenia) 10/2023 - 01/2006
10	Infections 12/2023 - 05/2013
8	Residual Neoplasm 01/2024 - 03/2017
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2011 - 08/2003
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2008 - 01/2003
6	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 01/2012
5	Pneumonia (Pneumonitis) 10/2023 - 10/2013
5	Pain (Aches) 01/2021 - 04/2008
5	Amyloidosis 10/2020 - 03/2004
4	Immunoglobulin Light-chain Amyloidosis 01/2023 - 01/2018
4	Anemia 11/2018 - 10/2015
4	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2017 - 07/2007
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2013 - 03/2008
4	Renal Insufficiency (Renal Failure) 06/2013 - 12/2008
3	Inflammation (Inflammations) 04/2024 - 03/2011
3	Polyneuropathies (Polyneuropathy) 09/2023 - 01/2010
3	COVID-19 01/2023 - 01/2020
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2022 - 04/2004
3	Testicular Neoplasms (Testicular Cancer) 01/2022 - 10/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 08/2005
2	Septic Shock (Toxic Shock Syndrome) 10/2023 - 10/2021
2	Bone Diseases (Bone Disease) 01/2022 - 10/2015
2	Lymphopenia (Lymphocytopenia) 10/2021 - 11/2018
2	Hypertension (High Blood Pressure) 10/2021 - 07/2010
2	Lymphoma (Lymphomas) 01/2021 - 07/2007
2	Fatigue 10/2018 - 10/2013
2	Neuralgia (Stump Neuralgia) 01/2018 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 01/2017
2	Painful Neuropathy 01/2018 - 01/2015
2	Thrombosis (Thrombus) 10/2016 - 07/2010
2	Hematologic Neoplasms (Hematological Malignancy) 01/2015 - 10/2010
2	B-Cell Lymphoma (Lymphoma, B Cell) 06/2011 - 06/2008
2	Thromboembolism 06/2011 - 04/2008
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2011 - 10/2008
2	Refractory Anemia 04/2010 - 09/2009
2	Pulmonary Embolism 12/2008 - 10/2008

Drug/Important Bio-Agent (IBA)

85	Bortezomib (Velcade)FDA Link 01/2024 - 06/2005
75	Dexamethasone (Maxidex)FDA LinkGeneric 02/2024 - 03/2003
45	Lenalidomide (CC 5013)FDA Link 01/2024 - 04/2008
37	Thalidomide (Thalomid)FDA Link 09/2023 - 01/2008
26	daratumumabIBA 01/2024 - 01/2016
20	Proteasome InhibitorsIBA 10/2023 - 01/2006
17	Melphalan (Alkeran)FDA LinkGeneric 10/2020 - 03/2003
16	pomalidomideIBA 11/2023 - 10/2013
12	Monoclonal AntibodiesIBA 01/2022 - 06/2008
11	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2002
11	Prednisone (Sone)FDA LinkGeneric 06/2020 - 01/2003
9	melflufenIBA 02/2024 - 04/2020
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2003
8	carfilzomibIBA 10/2022 - 07/2014
8	Immunomodulating AgentsIBA 01/2022 - 01/2010
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 01/2003
7	Vincristine (Oncovin)FDA LinkGeneric 05/2015 - 01/2003
7	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2013 - 04/2004
6	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 06/2007
6	liposomal doxorubicin (Doxil)FDA Link 07/2016 - 09/2007
5	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 05/2005
5	1-dodecylpyridoxal (PLD)IBA 07/2016 - 09/2007
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2012 - 08/2003
4	Alkylating AgentsIBA 11/2023 - 02/2012
4	ixazomibIBA 09/2023 - 12/2020
4	Chimeric Antigen ReceptorsIBA 01/2023 - 12/2019
4	thiamine triphosphorate (TTP)IBA 02/2021 - 03/2003
4	AnthracyclinesIBA 01/2018 - 07/2004
4	DNA (Deoxyribonucleic Acid)IBA 04/2017 - 04/2007
4	Imatinib Mesylate (Gleevec)FDA Link 08/2013 - 03/2008
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2010 - 12/2002
4	EnzymesIBA 11/2010 - 10/2006
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
3	Peptides (Polypeptides)IBA 11/2023 - 04/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023 - 05/2013
3	AntigensIBA 01/2022 - 10/2010
3	Daunorubicin (Cerubidine)FDA LinkGeneric 09/2009 - 07/2004
3	major vault proteinIBA 05/2007 - 12/2002
3	Green Fluorescent ProteinsIBA 02/2006 - 11/2003
2	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2023
2	VaccinesIBA 01/2023 - 12/2021
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2022 - 12/2002
2	CytokinesIBA 01/2021 - 04/2016
2	Complement System Proteins (Complement)IBA 12/2020 - 06/2008
2	AminopeptidasesIBA 09/2020 - 10/2010
2	Immunoglobulin G (IgG)IBA 11/2018 - 06/2014
2	Rituximab (Mabthera)FDA Link 01/2017 - 11/2013
2	CreatinineIBA 01/2016 - 12/2008
2	Amyloid (Amyloid Fibrils)IBA 05/2015 - 03/2004
2	Factor VIII (Coagulation Factor VIII)IBA 07/2010 - 07/2007

Therapy/Procedure

88	Therapeutics 01/2024 - 03/2003
24	Stem Cell Transplantation 01/2021 - 05/2003
18	Drug Therapy (Chemotherapy) 04/2024 - 01/2003
6	Transplantation 12/2023 - 09/2005
3	Aftercare (After-Treatment) 04/2024 - 01/2022
3	Induction Chemotherapy 04/2010 - 08/2003
2	Immunotherapy 10/2023 - 11/2011
2	Remission Induction 08/2020 - 03/2003
2	Drug Tapering 02/2012 - 04/2008